Product Information
PROVIGIL 100 MG TABLET is a brand product labeled by Apotex Corp., priced at $53.1528 per EA under NDC 60505485103. Its NADAC has been published 44 times since Oct 22, 2025.
FDA first approved this application on Dec 24, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Modafinil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Apotex Corp.NDC
60505485103
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MODAFINILApproval Type
New Drug (NDA)
FDA Application
NDA020717FDA Approved
12/24/1998
TE Code
AB
On Market Since
8/31/2025
Pharmacological Classes
Price Statistics
The NADAC for PROVIGIL 100 MG TABLET has been published 44 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $53.1528 per EA |
|---|---|
| All-time high | $53.1528 (Aug 19, 2026) |
| All-time low | $52.9095 (Apr 22, 2026) |
| 52-week high | $53.1528 |
| 52-week low | $52.9095 |
| Median price | $53.0281 |
| Average price | $53.0062 |
| Largest weekly change | -0.2% (Apr 22, 2026) |
| Weeks tracked | 44 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROVIGIL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROVIGIL 100 MG TABLET, manufactured by Apotex Corp., is $53.1528 per EA (NDC 60505485103), effective Aug 19, 2026.
How has the price of PROVIGIL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROVIGIL 100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for PROVIGIL 100 MG TABLET?
Since Oct 22, 2025, the NADAC for PROVIGIL 100 MG TABLET has ranged from a low of $52.9095 (Apr 22, 2026) to a high of $53.1528 (Aug 19, 2026), with a median of $53.0281 per EA.
Are there cheaper alternatives to PROVIGIL 100 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MODAFINIL 100 MG TABLET, is $0.2420 per EA — about 99% below PROVIGIL 100 MG TABLET.
Who manufactures PROVIGIL 100 MG TABLET?
PROVIGIL 100 MG TABLET (NDC 60505485103) is labeled by Apotex Corp., and CMS classifies it as a brand product.